U.S. stock market anomaly | Q1 performance exceeds expectations Hims & Hers Health (HIMS.US) surges over 10%

According to the Securities Times APP, on Tuesday, Hims & Hers Health (HIMS.US) surged more than 10%, closing at $46.46. In terms of news, the company reported first-quarter revenue of $586 million, exceeding FactSet's consensus estimate of $539 million. Adjusted EBITDA was $91.1 million, higher than the consensus expectation of $61 million. The company maintains its 2025 revenue guidance and slightly raised its full-year profit guidance.